M. Flesch - Concepedia

Author

M. Flesch

Sorbonne Université

Also Known As

M FLESCH, M Flesch, M. FLESCH, M. Flesch, MICHEL FLESCH, Michel Flesch, S F Williams, T André

100

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Hôpital Tenon Hôpital Saint-Antoine Centre Hospitalier Universitaire de Besançon Hôpital Foch

About

M. Flesch is an author at Sorbonne Université specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	479
2	Health Sciences	9	9	201
3	Cellular Therapies	3	3	52
4	Blood Transplantation	2	2	34
5	Public Health	1	1	34

M. Flesch

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study Christophe Tournigand, Andrés Cervantes, Arié Figer, Journal of Clinical Oncology	2006	799
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Gérard Lledo, Journal of Clinical Oncology	2009	394
Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial Thierry André, Philippe Colin, Christophe Louvet, Journal of Clinical Oncology	2003	259
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease P Hervé, M. Flesch, Pierre Tiberghien, Blood	1992	177
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease P Hervé, M. Flesch, Pierre Tiberghien, Blood	1992	142
Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer Aimery de Gramont, Marc Buyse, José Cortiñas Abrahantes, Journal of Clinical Oncology	2007	132
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial NC Gorin, B Coiffier, M. Hayat, Blood	1992	107
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study Christophe Louvet, Thierry André, Gérard Lledo, Journal of Clinical Oncology	2002	105
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients Marie-Christine Étienne-Grimaldi, G. Milano, Frédérique Maindrault‐Gœbel, British Journal of Clinical Pharmacology	2009	96
Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France) Marc Maynadié, François Girodon, I. Manivet-Janoray, Haematologica	2010	91

Page 1